Cognition, neural networks and neurotechnology

The Cognition, neural networks and neurotechnology laboratory (www.puiglab.org) investigates how neural networks encode cognition and whether they can be useful biomarkers of cognitive impairment in psychiatric and neurological disorders. We also collaborate to develop state-of-the-art neural devices based on graphene for the simultaneous recording and stimulation of brain tissue. Finally, we are also helping develop new light-activated drugs with potential to advance new technologies relevant for photomedicine.

The main aims of the laboratory are:

1) To unravel dysfunctional neural networks and circuits in preclinical models of psychiatric and neurological disorders that result in cognitive impairment.

2) To find novel therapeutical targets for cognitive impairment by understanding the cellular mechanisms of cognitive amelioration produced by pharmacological treatments, natural compounds, and cognitive stimulation in preclinical models.

3) To contribute to the development of state-of-the-art neurotechnologies for the treatment of brain disorders based on graphene and light.